- Home
- EVTL vs GNLX Comparison
EVTL vs GNLX Comparison
Compare EVTL & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVTL | GNLX |
|---|---|---|
| Founded | 2016 | 2001 |
| Country | United Kingdom | United States |
| Employees | 454 | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.7M | 113.6M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | EVTL | GNLX |
|---|---|---|
| Price | $2.34 | $2.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $12.70 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 2.8M | 160.7K |
| Earning Date | 03-24-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.47 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $2.29 |
| 52 Week High | $7.60 | $8.54 |
Technical Indicators
Market Signals| Indicator | EVTL | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 41.31 | 50.15 |
| Support Level | $2.20 | $2.39 |
| Resistance Level | $2.85 | $2.97 |
| Average True Range (ATR) | 0.21 | 0.24 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 14.92 | 39.86 |
Price Performance
Historical ComparisonAbout EVTL Vertical Aerospace Ltd.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.